Corcept Therapeutics Incorporated (0I3Q.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
As of 07:03PM BST. Market open.
| Previous close | 29.18 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 2,318 |
| Market cap | 28.978M |
| Beta (5Y monthly) | 0.50 |
| PE ratio (TTM) | 0.32 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
3 High Insider Ownership US Growth Companies With Earnings Growth Up To 70%
As global markets experience fluctuations influenced by economic data and geopolitical tensions, investors are keenly watching the U.S. market for stable investment opportunities. High insider ownership in growth companies can be a strong signal of confidence in the company’s future, making such stocks potentially attractive in these uncertain times.
- Simply Wall St.
Corcept Therapeutics First Quarter 2024 Earnings: Beats Expectations
Corcept Therapeutics ( NASDAQ:CORT ) First Quarter 2024 Results Key Financial Results Revenue: US$146.8m (up 39% from...
- Zacks
Corcept (CORT) Q1 Earnings & Revenues Surpass Estimates
Corcept (CORT) beats on both earnings and sales in the first quarter of 2024. The company increases revenue guidance for 2024.
© 2024 Yahoo. All rights reserved.